Semaglutide May Cut Cardiovascular Risk Before Weight Loss ...Middle East

Medscape - News
Semaglutide May Cut Cardiovascular Risk Before Weight Loss
In SELECT, semaglutide was associated with a 41% reduction in major CV events within 6 months — ie, before weight loss or full dosing was achieved. Medscape Medical News

Hence then, the article about semaglutide may cut cardiovascular risk before weight loss was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Semaglutide May Cut Cardiovascular Risk Before Weight Loss )

Apple Storegoogle play

Last updated :

Also on site :